Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.

Market sentiment signals for ArriVent BioPharma (AVBP): analyst consensus, short interest, options flow and insider activity.
Analyst Consensus
Buy
15 analysts
Options Flow (P/C)
—
Avg Consensus PT
$33
+108.3%
Highest Price Target
$50
+218.5%
Lowest Price Target
$18
+14.6%
Short Interest
18.2%
Declining — Bullish
Insider Activity (30d)
—
Short Interest — % of Float
| Date | Firm | Analyst & Accuracy | Upside / Downside | PT Change | Action | Rating |
|---|---|---|---|---|---|---|
| Oct 27, 2026 | Guggenheim | Michael Schmidt— | +91.1% | $18 → $30 | Maintained | Buy |
| Oct 20, 2026 | B. Riley Securities | Kalpit Patel— | +84.7% | $45 → $29 | Maintained | Buy |